Phi Therapeutics, Inc.
SEC Form D private-offering issuer in Biotechnology
Based based in SAN FRANCISCO, CALIFORNIA, Phi Therapeutics, Inc. works in sec form d - biotechnology.
Profile
Private US issuer recorded in the SEC Form D structured dataset for 2019Q2. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 1575000.
Within the sec form d - biotechnology space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in SAN FRANCISCO, CALIFORNIA.
Directory data places it at the Regulation D stage.
Recorded headcount: 1-10 employees.
Public records show total funding of about $1.6M.
| Sector | SEC Form D - Biotechnology |
|---|---|
| Headquarters | SAN FRANCISCO, CALIFORNIA |
| Country | United States |
| Employees | 1-10 |
| Stage | Regulation D |
| Total funding | $1,575,000 |
Website: phitherapeutics.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account